The Rising Era of “Immunoporosis”: Role of Immune System in the Pathophysiology of Osteoporosis

References

• de Villiers TJ, Goldstein SR. Bone health 2022: an update. Climacteric. 2022;25(1):1–3. doi:10.1080/13697137.2021.1965408
   PubMed Web of Science ®Google Scholar
• Dobbs MB, Buckwalter J, Saltzman C. Osteoporosis: the increasing role of the orthopaedist. Iowa Orthop J. 1999;19:43–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10847516
   PubMedGoogle Scholar
• Arron JR, Choi Y. Bone versus immune system. Nature. 2000;408(6812):535–536. doi:10.1038/35046196
   PubMed Web of Science ®Google Scholar
• Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473(2):139–146. doi:10.1016/j.abb.2008.03.018
   PubMed Web of Science ®Google Scholar
• Srivastava RK. Osteoimmunology The i Nexus i between bone and immune system. Front Biosci. 2018;23(2):4600. doi:10.2741/4600
   Web of Science ®Google Scholar
• Srivastava RK, Dar HY, Mishra PK. Immunoporosis: immunology of osteoporosis—role of T cells. Front Immunol. 2018;9. doi:10.3389/fimmu.2018.00657
   Web of Science ®Google Scholar
• Sapra L, Azam Z, Rani L, et al. “Immunoporosis”: immunology of osteoporosis. Proc Natl Acad Sci India Sect B Biol Sci. 2021;91:511–519. doi:10.1007/s40011-021-01238-x
   Google Scholar
• Cawley KM, Bustamante-Gomez NC, Guha AG, et al. Local production of osteoprotegerin by osteoblasts suppresses bone resorption. Cell Rep. 2020;32(10):108052. doi:10.1016/j.celrep.2020.108052
   PubMed Web of Science ®Google Scholar
• Cline‐Smith A, Axelbaum A, Shashkova E, et al. Ovariectomy activates chronic low‐grade inflammation mediated by memory T cells, which promotes osteoporosis in mice. J Bone Miner Res. 2020;35(6):1174–1187. doi:10.1002/jbmr.3966
   PubMed Web of Science ®Google Scholar
• Xing L, Bushnell TP, Carlson L, et al. NF-κB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. J Bone Miner Res. 2002;17(7):1200–1210. doi:10.1359/jbmr.2002.17.7.1200
   PubMed Web of Science ®Google Scholar
• von Gunten S, Simon H-U. Linking glucocorticoid-induced osteoporosis to osteoimmunology. Cell Death Dis. 2020;11(12):1026. doi:10.1038/s41419-020-03250-x
   PubMed Web of Science ®Google Scholar
• Tao Z, Wang J, Wen K, et al. Pyroptosis in osteoblasts: a novel hypothesis underlying the pathogenesis of osteoporosis. Front Endocrinol (Lausanne). 2021;11. doi:10.3389/fendo.2020.548812
   Web of Science ®Google Scholar
• Frech M, Schuster G, Andes FT, Schett G, Zaiss MM, Sarter K. RANKL-induced Btn2a2 – a T cell immunomodulatory molecule – during osteoclast differentiation fine-tunes bone resorption. Front Endocrinol (Lausanne). 2021;12. doi:10.3389/fendo.2021.685060
   PubMed Web of Science ®Google Scholar
• Gallois A, Lachuer J, Yvert G, et al. Genome-wide expression analyses establish dendritic cells as a new osteoclast precursor able to generate bone-resorbing cells more efficiently than monocytes. J Bone Miner Res. 2010;25(3):661–672. doi:10.1359/jbmr.090829
   PubMed Web of Science ®Google Scholar
• Alnaeeli M, Teng Y-TA. Dendritic cells differentiate into osteoclasts in bone marrow microenvironment in vivo. Blood. 2009;113(1):264–265. doi:10.1182/blood-2008-09-180836
   PubMed Web of Science ®Google Scholar
• Rivollier A, Mazzorana M, Tebib J, et al. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood. 2004;104(13):4029–4037. doi:10.1182/blood-2004-01-0041
   PubMed Web of Science ®Google Scholar
• Maitra R, Follenzi A, Yaghoobian A, et al. Dendritic cell-mediated in vivo bone resorption. J Immunol. 2010;185(3):1485–1491. doi:10.4049/jimmunol.0903560
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang Y, Tang R, et al. Dendritic cells-derived interferon-λ1 ameliorated inflammatory bone destruction through inhibiting osteoclastogenesis. Cell Death Dis. 2020;11(6):414. doi:10.1038/s41419-020-2612-z
   PubMed Web of Science ®Google Scholar
• Kylmäoja E, Nakamura M, Turunen S, et al. Peripheral blood monocytes show increased osteoclast differentiation potential compared to bone marrow monocytes. Heliyon. 2018;4(9):e00780. doi:10.1016/j.heliyon.2018.e00780
   PubMed Web of Science ®Google Scholar
• Deng F-Y, Lei S-F, Zhang Y, et al. Peripheral blood monocyte-expressed ANXA2 gene is involved in pathogenesis of osteoporosis in humans. Mol Cell Proteomics. 2011;10(11):M111.011700. doi:10.1074/mcp.M111.011700
   Web of Science ®Google Scholar
• Batoon L, Millard SM, Wullschleger ME, et al. CD169+ macrophages are critical for osteoblast maintenance and promote intramembranous and endochondral ossification during bone repair. Biomaterials. 2019;196:51–66. doi:10.1016/j.biomaterials.2017.10.033
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Movila A, Kataoka S, et al. Proinflammatory M1 macrophages inhibit RANKL-induced osteoclastogenesis. Infect Immun. 2016;84(10):2802–2812. doi:10.1128/IAI.00461-16
   PubMed Web of Science ®Google Scholar
• Dou C, Ding N, Zhao C, et al. Estrogen deficiency-mediated M2 macrophage osteoclastogenesis contributes to M1/M2 ratio alteration in ovariectomized osteoporotic mice. J Bone Miner Res. 2018;33(5):899–908. doi:10.1002/jbmr.3364
   PubMed Web of Science ®Google Scholar
• Yang J, Park O, Kim J, Kwon Y, Yun C, Han SH. Modulation of macrophage subtypes by IRF5 determines osteoclastogenic potential. J Cell Physiol. 2019;234(12):23033–23042. doi:10.1002/jcp.28863
   PubMed Web of Science ®Google Scholar
• Huang R, Wang X, Zhou Y, Xiao Y. RANKL-induced M1 macrophages are involved in bone formation. Bone Res. 2017;5(1):17019. doi:10.1038/boneres.2017.19
   PubMed Web of Science ®Google Scholar
• Théry C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep. 2011;3. doi:10.3410/B3-15
   PubMedGoogle Scholar
• Wei F, Li M, Crawford R, Zhou Y, Xiao Y. Exosome-integrated titanium oxide nanotubes for targeted bone regeneration. Acta Biomater. 2019;86:480–492. doi:10.1016/j.actbio.2019.01.006
   PubMed Web of Science ®Google Scholar
• Xiong Y, Chen L, Yan C, et al. M2 Macrophagy-derived exosomal miRNA-5106 induces bone mesenchymal stem cells towards osteoblastic fate by targeting salt-inducible kinase 2 and 3. J Nanobiotechnol. 2020;18(1):66. doi:10.1186/s12951-020-00622-5
   PubMed Web of Science ®Google Scholar
• Chamberlain CS, Kink JA, Wildenauer LA, et al. Exosome-educated macrophages and exosomes differentially improve ligament healing. Stem Cells. 2021;39(1):55–61. doi:10.1002/stem.3291
   PubMed Web of Science ®Google Scholar
• Bordbar A, Mo ML, Nakayasu ES, et al. Model‐driven multi‐omic data analysis elucidates metabolic immunomodulators of macrophage activation. Mol Syst Biol. 2012;8(1):558. doi:10.1038/msb.2012.21
   PubMed Web of Science ®Google Scholar
• Kim J-M, Jeong D, Kang HK, Jung SY, Kang SS, Min B-M. Osteoclast precursors display dynamic metabolic shifts toward accelerated glucose metabolism at an early stage of RANKL-stimulated osteoclast differentiation. Cell Physiol Biochem. 2007;20(6):935–946. doi:10.1159/000110454
   PubMedGoogle Scholar
• Artis D, Spits H. The biology of innate lymphoid cells. Nature. 2015;517(7534):293–301. doi:10.1038/nature14189
   PubMed Web of Science ®Google Scholar
• Eberl G, Colonna M, Di Santo JP, McKenzie ANJ. Innate lymphoid cells: a new paradigm in immunology. Science (80-). 2015;348(6237):aaa6566–aaa6566. doi:10.1126/science.aaa6566
   PubMed Web of Science ®Google Scholar
• Hirota K, Hashimoto M, Ito Y, et al. Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis. Immunity. 2018;48(6):1220–1232.e5. doi:10.1016/j.immuni.2018.04.009
   PubMed Web of Science ®Google Scholar
• Geremia A, Arancibia-Cárcamo CV, Fleming MPP, et al. IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med. 2011;208(6):1127–1133. doi:10.1084/jem.20101712
   PubMed Web of Science ®Google Scholar
• Kwong B, Rua R, Gao Y, et al. T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation. Nat Immunol. 2017;18(10):1117–1127. doi:10.1038/ni.3816
   PubMed Web of Science ®Google Scholar
• Fazekas B, Moreno-Olivera A, Kelly Y, et al. Alterations in circulating lymphoid cell populations in systemic small vessel vasculitis are non-specific manifestations of renal injury. Clin Exp Immunol. 2018;191(2):180–188. doi:10.1111/cei.13058
   PubMed Web of Science ®Google Scholar
• Ke K, Chen T, Arra M, Mbalaviele G, Swarnkar G, Abu‐Amer Y. Attenuation of NF‐κB in intestinal epithelial cells is sufficient to mitigate the bone loss comorbidity of experimental mouse colitis. J Bone Miner Res. 2019;34(10):1880–1893. doi:10.1002/jbmr.3759
   PubMed Web of Science ®Google Scholar
• Mikami Y, Scarno G, Zitti B, et al. NCR + ILC3 maintain larger STAT4 reservoir via T‐BET to regulate type 1 features upon IL‐23 stimulation in mice. Eur J Immunol. 2018;48(7):1174–1180. doi:10.1002/eji.201847480
   PubMed Web of Science ®Google Scholar
• Bernink JH, Krabbendam L, Germar K, et al. Interleukin-12 and −23 control plasticity of CD127+ group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity. 2015;43(1):146–160. doi:10.1016/j.immuni.2015.06.019
   PubMed Web of Science ®Google Scholar
• Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature. 2000;408(6812):600–605. doi:10.1038/35046102
   PubMed Web of Science ®Google Scholar
• Omata Y, Frech M, Lucas S, et al. Type 2 innate lymphoid cells inhibit the differentiation of osteoclasts and protect from ovariectomy-induced bone loss. Bone. 2020;136:115335. doi:10.1016/j.bone.2020.115335
   PubMed Web of Science ®Google Scholar
• Cephus J, Fuseini H, Davis JB, Yung JA, Sucharski H, Newcomb DC. Estrogen receptor alpha signaling increases ILC2-mediated allergic airway inflammation. J Allergy Clin Immunol. 2019;143(2):AB2. doi:10.1016/j.jaci.2018.12.006
   Web of Science ®Google Scholar
• Omata Y, Frech M, Primbs T, et al. Group 2 innate lymphoid cells attenuate inflammatory arthritis and protect from bone destruction in mice. Cell Rep. 2018;24(1):169–180. doi:10.1016/j.celrep.2018.06.005
   PubMed Web of Science ®Google Scholar
• Seehus CR, Kadavallore A, de la Torre B, et al. Alternative activation generates IL-10 producing type 2 innate lymphoid cells. Nat Commun. 2017;8(1):1900. doi:10.1038/s41467-017-02023-z
   PubMed Web of Science ®Google Scholar
• Howard E, Lewis G, Galle-Treger L, et al. IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates cellular metabolism, and ameliorates airway hyperreactivity. J Allergy Clin Immunol. 2021;147(4):1281–1295.e5. doi:10.1016/j.jaci.2020.08.024
   PubMed Web of Science ®Google Scholar
• Momiuchi Y, Motomura Y, Suga E, et al. Group 2 innate lymphoid cells in bone marrow regulate osteoclastogenesis in a reciprocal manner via RANKL, GM-CSF and IL-13. Int Immunol. 2021;33(11):573–585. doi:10.1093/intimm/dxab062
   PubMed Web of Science ®Google Scholar
• Di Luccia B, Gilfillan S, Cella M, Colonna M, Huang S-C-C. ILC3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands. J Exp Med. 2019;216(10):2231–2241. doi:10.1084/jem.20180549
   PubMed Web of Science ®Google Scholar
• Takaki-Kuwahara A, Arinobu Y, Miyawaki K, et al. CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines. Arthritis Res Ther. 2019;21(1):198. doi:10.1186/s13075-019-1984-x
   PubMed Web of Science ®Google Scholar
• Leijten EFA, Van Kempen TS, Boes M, et al. Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid. Arthritis Rheumatol. 2015;67(10):2673–2678. doi:10.1002/art.39261
   PubMed Web of Science ®Google Scholar
• Ciccia F, Guggino G, Rizzo A, et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann Rheum Dis. 2015;74(9):1739–1747. doi:10.1136/annrheumdis-2014-206323
   PubMed Web of Science ®Google Scholar
• Tyagi AM, Srivastava K, Mansoori MN, Trivedi R, Chattopadhyay N, Singh D. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS One. 2012;7(9):e44552. doi:10.1371/journal.pone.0044552
   PubMed Web of Science ®Google Scholar
• Dar HY, Shukla P, Mishra PK, et al. Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balance. Bone Reports. 2018;8:46–56. doi:10.1016/j.bonr.2018.02.001
   PubMedGoogle Scholar
• Sapra L, Dar HY, Bhardwaj A, et al. Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice. Sci Rep. 2021;11(1):1807. doi:10.1038/s41598-020-80536-2
   PubMed Web of Science ®Google Scholar
• Wang S, Xia P, Chen Y, et al. Regulatory innate lymphoid cells control innate intestinal inflammation. Cell. 2017;171(1):201–216.e18. doi:10.1016/j.cell.2017.07.027
   PubMed Web of Science ®Google Scholar
• Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18(5):693–704. doi:10.1038/nm.2755
   PubMed Web of Science ®Google Scholar
• Biosse-Duplan M, Baroukh B, Dy M, de Vernejoul M-C, Saffar J-L. Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. Am J Pathol. 2009;174(4):1426–1434. doi:10.2353/ajpath.2009.080871
   PubMed Web of Science ®Google Scholar
• Kroner J, Kovtun A, Kemmler J, et al. Mast cells are critical regulators of bone fracture-induced inflammation and osteoclast formation and activity. J Bone Miner Res. 2017;32(12):2431–2444. doi:10.1002/jbmr.3234
   PubMed Web of Science ®Google Scholar
• Zechner C, Gruntmanis U. Systemic mastocytosis with decreased bone density and fractures. Mayo Clin Proc. 2015;90(6):843–844. doi:10.1016/j.mayocp.2014.10.014
   PubMed Web of Science ®Google Scholar
• Lind T, Gustafson A-M, Calounova G, et al. Increased bone mass in female mice lacking mast cell chymase. PLoS One. 2016;11(12):e0167964. doi:10.1371/journal.pone.0167964
   PubMed Web of Science ®Google Scholar
• Fischer V, Ragipoglu D, Diedrich J, et al. Mast cells trigger disturbed bone healing in osteoporotic mice. J Bone Miner Res. 2021. doi:10.1002/jbmr.4455
   Web of Science ®Google Scholar
• Ginaldi L, De Martinis M, Ciccarelli F, et al. Increased levels of interleukin 31 (IL-31) in osteoporosis. BMC Immunol. 2015;16(1):60. doi:10.1186/s12865-015-0125-9
   PubMed Web of Science ®Google Scholar
• Moonen CGJ, de Vries TJ, Rijkschroeff P, Poubelle PE, Nicu EA, Loos BG. The possible role of neutrophils in the induction of osteoclastogenesis. J Immunol Res. 2019;2019:1–14. doi:10.1155/2019/8672604
   Web of Science ®Google Scholar
• Chakravarti A, Raquil M-A, Tessier P, Poubelle PE. Surface RANKL of Toll-like receptor 4–stimulated human neutrophils activates osteoclastic bone resorption. Blood. 2009;114(8):1633–1644. doi:10.1182/blood-2008-09-178301
   PubMed Web of Science ®Google Scholar
• Sugisaki R, Miyamoto Y, Yoshimura K, et al. Possible involvement of elastase in enhanced osteoclast differentiation by neutrophils through degradation of osteoprotegerin. Bone. 2020;132:115216. doi:10.1016/j.bone.2019.115216
   PubMed Web of Science ®Google Scholar
• Yilmaz H, Uyfun M, Yilmaz TS, et al. Neutrophil-lymphocyte ratio may be superior to C-reactive protein for predicting the occurrence of postmenopausal osteoporosis. Endocr Regul. 2014;48(01):25–33. doi:10.4149/endo_2014_01_25
   PubMedGoogle Scholar
• Jiang J, Liu X, Lai B, et al. Correlational analysis between neutrophil granulocyte levels and osteonecrosis of the femoral head. BMC Musculoskelet Disord. 2019;20(1):393. doi:10.1186/s12891-019-2778-7
   PubMed Web of Science ®Google Scholar
• Bastian OW, Koenderman L, Alblas J, Leenen LPH, Blokhuis TJ. Neutrophils contribute to fracture healing by synthesizing fibronectin + extracellular matrix rapidly after injury. Clin Immunol. 2016;164:78–84. doi:10.1016/j.clim.2016.02.001
   PubMed Web of Science ®Google Scholar
• Kovtun A, Bergdolt S, Wiegner R, Radermacher P, Huber-Lang M, Ignatius A. The crucial role of neutrophil granulocytes in bone fracture healing. Eur Cells Mater. 2016;32:152–162. doi:10.22203/eCM.v032a10
   PubMed Web of Science ®Google Scholar
• Fischer KD, Agrawal DK. Hematopoietic stem and progenitor cells in inflammation and allergy. Front Immunol. 2013;4. doi:10.3389/fimmu.2013.00428
   Web of Science ®Google Scholar
• Ginaldi L, De Martinis M, Saitta S, et al. Interleukin-33 serum levels in postmenopausal women with osteoporosis. Sci Rep. 2019;9(1):3786. doi:10.1038/s41598-019-40212-6
   PubMed Web of Science ®Google Scholar
• Soderstrom K, Stein E, Colmenero P, et al. Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc Natl Acad Sci. 2010;107(29):13028–13033. doi:10.1073/pnas.1000546107
   PubMed Web of Science ®Google Scholar
• Feng S, Madsen SH, Viller NN, et al. Interleukin-15-activated natural killer cells kill autologous osteoclasts via LFA-1, DNAM-1 and TRAIL, and inhibit osteoclast-mediated bone erosion in vitro. Immunology. 2015;145(3):367–379. doi:10.1111/imm.12449
   PubMed Web of Science ®Google Scholar
• Vandenhaute J, Avau A, Filtjens J, et al. Regulatory role for NK cells in a mouse model of systemic juvenile idiopathic arthritis. J Immunol. 2019;203(12):3339–3348. doi:10.4049/jimmunol.1900510
   PubMed Web of Science ®Google Scholar
• Takeda H, Kikuchi T, Soboku K, et al. Effect of IL-15 and natural killer cells on osteoclasts and osteoblasts in a mouse coculture. Inflammation. 2014;37(3):657–669. doi:10.1007/s10753-013-9782-0
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136(7):2348–2357.
   PubMed Web of Science ®Google Scholar
• Zhang J, Fu Q, Ren Z, et al. Changes of serum cytokines-related Th1/Th2/Th17 concentration in patients with postmenopausal osteoporosis. Gynecol Endocrinol. 2015;31(3):183–190. doi:10.3109/09513590.2014.975683
   PubMed Web of Science ®Google Scholar
• Mangashetti LS, Khapli SM, Wani MR. IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-κB and Ca 2+ signaling. J Immunol. 2005;175(2):917–925. doi:10.4049/jimmunol.175.2.917
   PubMed Web of Science ®Google Scholar
• Yamada A, Takami M, Kawawa T, et al. Interleukin-4 inhibition of osteoclast differentiation is stronger than that of interleukin-13 and they are equivalent for induction of osteoprotegerin production from osteoblasts. Immunology. 2007;120(4):573–579. doi:10.1111/j.1365-2567.2006.02538.x
   PubMed Web of Science ®Google Scholar
• Bendixen AC, Shevde NK, Dienger KM, Willson TM, Funk CD, Pike JW. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor 1. Proc Natl Acad Sci. 2001;98(5):2443–2448. doi:10.1073/pnas.041493198
   PubMed Web of Science ®Google Scholar
• Moreno JL, Kaczmarek M, Keegan AD, Tondravi M. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood. 2003;102(3):1078–1086. doi:10.1182/blood-2002-11-3437
   PubMed Web of Science ®Google Scholar
• Gao Y, Grassi F, Ryan MR, et al. IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest. 2007;117(1):122–132. doi:10.1172/JCI30074
   PubMed Web of Science ®Google Scholar
• Ji J-D, Park-Min K-H, Shen Z, et al. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-γ in human osteoclast precursors. J Immunol. 2009;183(11):7223–7233. doi:10.4049/jimmunol.0900072
   PubMed Web of Science ®Google Scholar
• Place DE, Malireddi RKS, Kim J, Vogel P, Yamamoto M, Kanneganti T-D. Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins. Nat Commun. 2021;12(1):496. doi:10.1038/s41467-020-20807-8
   PubMed Web of Science ®Google Scholar
• Sapra L, Bhardwaj A, Mishra PK, et al. Regulatory B cells (Bregs) inhibit osteoclastogenesis and play a potential role in ameliorating ovariectomy-induced bone loss. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.691081
   PubMed Web of Science ®Google Scholar
• Yadav M, Stephan S, Bluestone JA. Peripherally induced tregs – role in immune homeostasis and autoimmunity. Front Immunol. 2013;4. doi:10.3389/fimmu.2013.00232
   PubMed Web of Science ®Google Scholar
• Cebula A, Seweryn M, Rempala GA, et al. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature. 2013;497(7448):258–262. doi:10.1038/nature12079
   PubMed Web of Science ®Google Scholar
• Goodman WA, Bedoyan SM, Havran HL, Richardson B, Cameron MJ, Pizarro TT. Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine. Proc Natl Acad Sci U S A. 2020;117(29):17166–17176. doi:10.1073/pnas.2002266117
   PubMed Web of Science ®Google Scholar
• Opstelten R, de Kivit S, Slot MC, et al. GPA33: a marker to identify stable human regulatory T cells. J Immunol. 2020;204(12):3139–3148. doi:10.4049/jimmunol.1901250
   PubMed Web of Science ®Google Scholar
• Luo C, Wang L, Sun C, Li D. Estrogen enhances the functions of CD4+CD25+Foxp3+ regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cell Mol Immunol. 2011;8(1):50–58. doi:10.1038/cmi.2010.54
   PubMed Web of Science ®Google Scholar
• Houde N, Chamoux E, Bisson M, Roux S. Transforming growth factor-β1 (TGF-β1) induces human osteoclast apoptosis by up-regulating bim. J Biol Chem. 2009;284(35):23397–23404. doi:10.1074/jbc.M109.019372
   PubMed Web of Science ®Google Scholar
• Fischer L, Herkner C, Kitte R, et al. Foxp3+ regulatory T cells in bone and hematopoietic homeostasis. Front Endocrinol (Lausanne). 2019;10. doi:10.3389/fendo.2019.00578
   Web of Science ®Google Scholar
• Yu M, D’Amelio P, Tyagi AM, et al. Regulatory T cells are expanded by Teriparatide treatment in humans and mediate intermittent PTH ‐induced bone anabolism in mice. EMBO Rep. 2018;19(1):156–171. doi:10.15252/embr.201744421
   PubMed Web of Science ®Google Scholar
• Tsukasaki M, Takayanagi H. Osteoimmunology: evolving concepts in bone–immune interactions in health and disease. Nat Rev Immunol. 2019;19(10):626–642. doi:10.1038/s41577-019-0178-8
   PubMed Web of Science ®Google Scholar
• Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor rorγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126(6):1121–1133. doi:10.1016/j.cell.2006.07.035
   PubMed Web of Science ®Google Scholar
• Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203(12):2673–2682. doi:10.1084/jem.20061775
   PubMed Web of Science ®Google Scholar
• Scheffler JM, Grahnemo L, Engdahl C, et al. Interleukin 17A: a Janus-faced regulator of osteoporosis. Sci Rep. 2020;10(1):5692. doi:10.1038/s41598-020-62562-2
   PubMed Web of Science ®Google Scholar
• Yu M, Malik Tyagi A, Li J-Y, et al. PTH induces bone loss via microbial-dependent expansion of intestinal TNF+ T cells and Th17 cells. Nat Commun. 2020;11(1):468. doi:10.1038/s41467-019-14148-4
   PubMed Web of Science ®Google Scholar
• Yu M, Pal S, Paterson CW, et al. Ovariectomy induces bone loss via microbial-dependent trafficking of intestinal TNF+ T cells and Th17 cells. J Clin Invest. 2021;131(4). doi:10.1172/JCI143137
   Web of Science ®Google Scholar
• Bhadricha H, Patel V, Singh AK, et al. Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women. Sci Rep. 2021;11(1):16155. doi:10.1038/s41598-021-95640-0
   PubMed Web of Science ®Google Scholar
• Wo J, Zhang F, Li Z, Sun C, Zhang W, Sun G. The role of gamma-delta T cells in diseases of the central nervous system. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.580304
   PubMed Web of Science ®Google Scholar
• Phalke SP, Chiplunkar SV. Activation status of γδ T cells dictates their effect on osteoclast generation and bone resorption. Bone Reports. 2015;3:95–103. doi:10.1016/j.bonr.2015.10.004
   PubMedGoogle Scholar
• Colburn NT, Zaal KJM, Wang F, Tuan RS. A role for γ/δ T cells in a mouse model of fracture healing. Arthritis Rheum. 2009;60(6):1694–1703. doi:10.1002/art.24520
   PubMed Web of Science ®Google Scholar
• Ono T, Okamoto K, Nakashima T, et al. IL-17-producing γδ T cells enhance bone regeneration. Nat Commun. 2016;7(1):10928. doi:10.1038/ncomms10928
   PubMed Web of Science ®Google Scholar
• Kaplan MH. Th9 cells: differentiation and disease. Immunol Rev. 2013;252(1):104–115. doi:10.1111/imr.12028
   PubMed Web of Science ®Google Scholar
• Stanko K, Iwert C, Appelt C, et al. CD96 expression determines the inflammatory potential of IL-9–producing Th9 cells. Proc Natl Acad Sci. 2018;115(13):E2940–E2949. doi:10.1073/pnas.1708329115
   PubMed Web of Science ®Google Scholar
• Kar S, Gupta R, Malhotra R, et al. Interleukin-9 facilitates osteoclastogenesis in rheumatoid arthritis. Int J Mol Sci. 2021;22(19):10397. doi:10.3390/ijms221910397
   PubMed Web of Science ®Google Scholar
• Plank MW, Kaiko GE, Maltby S, et al. Th22 cells form a distinct Th lineage from Th17 cells in vitro with unique transcriptional properties and tbet-dependent Th1 plasticity. J Immunol. 2017;198(5):2182–2190. doi:10.4049/jimmunol.1601480
   PubMed Web of Science ®Google Scholar
• Yeste A, Mascanfroni ID, Nadeau M, et al. IL-21 induces IL-22 production in CD4+ T cells. Nat Commun. 2014;5(1):3753. doi:10.1038/ncomms4753
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Nakayamada S, Kubo S, et al. Th22 cells promote osteoclast differentiation via production of IL-22 in rheumatoid arthritis. Front Immunol. 2018;9. doi:10.3389/fimmu.2018.02901
   Web of Science ®Google Scholar
• Shi L, Ji Q, Liu L, et al. IL‐22 produced by Th22 cells aggravates atherosclerosis development in ApoE −/− mice by enhancing DC‐induced Th17 cell proliferation. J Cell Mol Med. 2020;24(5):3064–3078. doi:10.1111/jcmm.14967
   PubMed Web of Science ®Google Scholar
• Monasterio G, Budini V, Fernández B, et al. IL-22-expressing CD4 + AhR + T lymphocytes are associated with RANKL-mediated alveolar bone resorption during experimental periodontitis. J Periodontal Res. 2019;54(5):513–524. doi:10.1111/jre.12654
   PubMed Web of Science ®Google Scholar
• Ma J, Zhu C, Ma B, et al. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol. 2012;2012:1–7. doi:10.1155/2012/827480
   Google Scholar
• Niu Q, Huang Z, Wu X, et al. Enhanced IL-6/phosphorylated STAT3 signaling is related to the imbalance of circulating T follicular helper/T follicular regulatory cells in patients with rheumatoid arthritis. Arthritis Res Ther. 2018;20(1):200. doi:10.1186/s13075-018-1690-0
   PubMed Web of Science ®Google Scholar
• Li W, Wei C, Xu L, et al. Schistosome infection promotes osteoclast-mediated bone loss. PLOS Pathog. 2021;17(3):e1009462. doi:10.1371/journal.ppat.1009462
   PubMed Web of Science ®Google Scholar
• Kim D-H, Park H-J, Park H-S, et al. Estrogen receptor α in T cells suppresses follicular helper T cell responses and prevents autoimmunity. Exp Mol Med. 2019;51(4):1–9. doi:10.1038/s12276-019-0237-z
   Web of Science ®Google Scholar
• Streicher C, Heyny A, Andrukhova O, et al. Estrogen regulates bone turnover by targeting RANKL expression in bone lining cells. Sci Rep. 2017;7(1):6460. doi:10.1038/s41598-017-06614-0
   PubMed Web of Science ®Google Scholar
• Ono-Ohmachi A, Yamada S, Uno S, et al. Effector memory CD4+T cells in mesenteric lymph nodes mediate bone loss in food-allergic enteropathy model mice, creating IL-4 dominance. Mucosal Immunol. 2021;14(6):1335–1346. doi:10.1038/s41385-021-00434-2
   PubMed Web of Science ®Google Scholar
• Hu M, Bassett JHD, Danks L, et al. Activated invariant NKT cells regulate osteoclast development and function. J Immunol. 2011;186(5):2910–2917. doi:10.4049/jimmunol.1002353
   PubMed Web of Science ®Google Scholar
• Tilkeridis K, Kiziridis G, Ververidis A, et al. Immunoporosis: a new role for invariant natural killer T (NKT) cells through overexpression of nuclear factor-κB ligand (RANKL). Med Sci Monit. 2019;25:2151–2158. doi:10.12659/MSM.912119
   PubMed Web of Science ®Google Scholar
• Li S, Liu Q, Wu D, et al. PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling. Cell Death Dis. 2020;11(9):762. doi:10.1038/s41419-020-02947-3
   PubMed Web of Science ®Google Scholar
• Onal M, Xiong J, Chen X, et al. Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. J Biol Chem. 2012;287(35):29851–29860. doi:10.1074/jbc.M112.377945
   PubMed Web of Science ®Google Scholar
• Fujiwara Y, Piemontese M, Liu Y, Thostenson JD, Xiong J, O’Brien CA. RANKL (receptor activator of nfκb ligand) produced by osteocytes is required for the increase in B cells and bone loss caused by estrogen deficiency in mice. J Biol Chem. 2016;291(48):24838–24850. doi:10.1074/jbc.M116.742452
   PubMed Web of Science ®Google Scholar
• Sun W, Meednu N, Rosenberg A, et al. B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation. Nat Commun. 2018;9(1):5127. doi:10.1038/s41467-018-07626-8
   PubMed Web of Science ®Google Scholar
• Bernardi AI, Andersson A, Grahnemo L, et al. Effects of lasofoxifene and bazedoxifene on B cell development and function. Immun Inflamm Dis. 2014;2(4):214–225. doi:10.1002/iid3.37
   PubMedGoogle Scholar
• Flores-Borja F, Bosma A, Ng D, et al. CD19 + CD24 hi CD38 hi B cells maintain regulatory T cells while limiting T H 1 and T H 17 differentiation. Sci Transl Med. 2013;5:173. doi:10.1126/scitranslmed.3005407
   Web of Science ®Google Scholar
• Yanaba K, Bouaziz J-D, Haas KM, Poe JC, Fujimoto M, Tedder TF. A rB cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008;28(5):639–650. doi:10.1016/j.immuni.2008.03.017
   PubMed Web of Science ®Google Scholar
• Sun G, Wang Y, Ti Y, Wang J, Zhao J, Qian H. Regulatory B cell is critical in bone union process through suppressing proinflammatory cytokines and stimulating Foxp3 in Treg cells. Clin Exp Pharmacol Physiol. 2017;44(4):455–462. doi:10.1111/1440-1681.12719
   PubMed Web of Science ®Google Scholar
• Sakkas LI, Mavropoulos A, Perricone C, Bogdanos DP. IL-35: a new immunomodulator in autoimmune rheumatic diseases. Immunol Res. 2018;66(3):305–312. doi:10.1007/s12026-018-8998-3
   PubMed Web of Science ®Google Scholar
• Wang R-X, Yu C-R, Dambuza IM, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med. 2014;20(6):633–641. doi:10.1038/nm.3554
   PubMed Web of Science ®Google Scholar
• Talaat RM, Sidek A, Mosalem A, Kholief A. Effect of bisphosphonates treatment on cytokine imbalance between TH17 and Treg in osteoporosis. Inflammopharmacology. 2015;23(2–3):119–125. doi:10.1007/s10787-015-0233-4
   PubMed Web of Science ®Google Scholar
• Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576–590. doi:10.1038/s41574-018-0059-4
   PubMed Web of Science ®Google Scholar
• Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S. Inflammaging and ‘Garb-aging’. Trends Endocrinol Metab. 2017;28(3):199–212. doi:10.1016/j.tem.2016.09.005
   PubMed Web of Science ®Google Scholar
• Demontiero O, Vidal C, Duque G. Aging and bone loss: new insights for the clinician. Ther Adv Musculoskelet Dis. 2012;4(2):61–76. doi:10.1177/1759720X11430858
   PubMedGoogle Scholar
• Kim O-H, Kim H, Kang J, et al. Impaired phagocytosis of apoptotic cells causes accumulation of bone marrow-derived macrophages in aged mice. BMB Rep. 2017;50(1):43–48. doi:10.5483/BMBRep.2017.50.1.167
   PubMed Web of Science ®Google Scholar
• Bhardwaj A, Sapra L, Tiwari A, Mishra PK, Sharma S, Srivastava RK. “Osteomicrobiology”: the nexus between bone and bugs. Front Microbiol. 2022;12. doi:10.3389/fmicb.2021.812466
   PubMed Web of Science ®Google Scholar
• Rosser EC, Oleinika K, Tonon S, et al. Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production. Nat Med. 2014;20(11):1334–1339. doi:10.1038/nm.3680
   PubMed Web of Science ®Google Scholar
• Rosser EC, Piper CJM, Matei DE, et al. Microbiota-derived metabolites suppress arthritis by amplifying Aryl-hydrocarbon receptor activation in regulatory B cells. Cell Metab. 2020;31(4):837–851.e10. doi:10.1016/j.cmet.2020.03.003
   PubMed Web of Science ®Google Scholar
• Tyagi AM, Darby TM, Hsu E, et al. The gut microbiota is a transmissible determinant of skeletal maturation. Elife. 2021;10. doi:10.7554/eLife.64237
   PubMed Web of Science ®Google Scholar
• Dar HY, Pal S, Shukla P, et al. Bacillus clausii inhibits bone loss by skewing Treg-Th17 cell equilibrium in postmenopausal osteoporotic mice model. Nutrition. 2018;54:118–128. doi:10.1016/j.nut.2018.02.013
   PubMed Web of Science ®Google Scholar
• Piper CJM, Rosser EC, Oleinika K, et al. Aryl hydrocarbon receptor contributes to the transcriptional program of IL-10-producing regulatory B cells. Cell Rep. 2019;29(7):1878–1892.e7. doi:10.1016/j.celrep.2019.10.018
   PubMed Web of Science ®Google Scholar
• Lilian Ilesanmi-Oyelere B, Cathorina Kruger M. Prebiotics, probiotics and synbiotic for bone health. In: Prebiotics and Probiotics - from Food to Health [Working Title]. IntechOpen; 2021. doi10.5772/intechopen.100525
   Google Scholar
• Whisner CM, Castillo LF. Prebiotics, bone and mineral metabolism. Calcif Tissue Int. 2018;102(4):443–479. doi:10.1007/s00223-017-0339-3
   PubMed Web of Science ®Google Scholar
• Porwal K, Pal S, Kulkarni C, et al. A prebiotic, short-chain fructo-oligosaccharides promotes peak bone mass and maintains bone mass in ovariectomized rats by an osteogenic mechanism. Biomed Pharmacother. 2020;129:110448. doi:10.1016/j.biopha.2020.110448
   PubMed Web of Science ®Google Scholar
• Timan P, Rojanasthien N, Manorot M, Sangdee C, Teekachunhatean S. Effect of synbiotic fermented milk on oral bioavailability of isoflavones in postmenopausal women. Int J Food Sci Nutr. 2014;65(6):761–767. doi:10.3109/09637486.2014.908169
   PubMed Web of Science ®Google Scholar
• Iseme RA, Mcevoy M, Kelly B, Agnew L, Walker FR, Attia J. Is osteoporosis an autoimmune mediated disorder? Bone Reports. 2017;7:121–131. doi:10.1016/j.bonr.2017.10.003
   PubMedGoogle Scholar
• Donham C, Chicana B, Robling AG, et al. Sclerostin depletion induces inflammation in the bone marrow of mice. Int J Mol Sci. 2021;22(17):9111. doi:10.3390/ijms22179111
   PubMed Web of Science ®Google Scholar
• Mbalaviele G, Novack DV, Schett G, Teitelbaum SL. Inflammatory osteolysis: a conspiracy against bone. J Clin Invest. 2017;127(6):2030–2039. doi:10.1172/JCI93356
   PubMed Web of Science ®Google Scholar
• Shiratori T, Kyumoto-Nakamura Y, Kukita A, et al. IL-1β induces pathologically activated osteoclasts bearing extremely high levels of resorbing activity: a possible pathological subpopulation of osteoclasts, accompanied by suppressed expression of kindlin-3 and talin-1. J Immunol. 2018;200(1):218–228. doi:10.4049/jimmunol.1602035
   PubMed Web of Science ®Google Scholar
• Hengartner N-E, Fiedler J, Ignatius A, Brenner RE. IL-1β inhibits human osteoblast migration. Mol Med. 2013;19(1):36–42. doi:10.2119/molmed.2012.00058
   PubMed Web of Science ®Google Scholar
• Yoshitake F, Itoh S, Narita H, Ishihara K, Ebisu S. Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-κB signaling pathways. J Biol Chem. 2008;283(17):11535–11540. doi:10.1074/jbc.M607999200
   PubMed Web of Science ®Google Scholar
• Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone. 2003;33(1):28–37. doi:10.1016/S8756-3282(03)00086-3
   PubMed Web of Science ®Google Scholar
• Okabe I, Kikuchi T, Mogi M, et al. IL-15 and RANKL play a synergistically important role in osteoclastogenesis. J Cell Biochem. 2017;118(4):739–747. doi:10.1002/jcb.25726
   PubMed Web of Science ®Google Scholar
• Loro E, Ramaswamy G, Chandra A, et al. IL15RA is required for osteoblast function and bone mineralization. Bone. 2017;103:20–30. doi:10.1016/j.bone.2017.06.003
   PubMed Web of Science ®Google Scholar
• Song L, Tan J, Wang Z, et al. Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages. Mol Med Rep. 2019. doi:10.3892/mmr.2019.10155
   Web of Science ®Google Scholar
• Kim Y-G, Park J-W, Lee J-M, et al. IL-17 inhibits osteoblast differentiation and bone regeneration in rat. Arch Oral Biol. 2014;59(9):897–905. doi:10.1016/j.archoralbio.2014.05.009
   PubMed Web of Science ®Google Scholar
• Mansoori MN, Shukla P, Kakaji M, et al. IL-18BP is decreased in osteoporotic women: prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation. Sci Rep. 2016;6(1):33680. doi:10.1038/srep33680
   PubMed Web of Science ®Google Scholar
• Makiishi-Shimobayashi C, Tsujimura T, Iwasaki T, et al. Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells. Biochem Biophys Res Commun. 2001;281(2):361–366. doi:10.1006/bbrc.2001.4380
   PubMed Web of Science ®Google Scholar
• Bolzoni M, Ronchetti D, Storti P, et al. IL21R expressing CD14 + CD16 + monocytes expand in multiple myeloma patients leading to increased osteoclasts. Haematologica. 2017;102(4):773–784. doi:10.3324/haematol.2016.153841
   PubMed Web of Science ®Google Scholar
• El-Zayadi AA, Jones EA, Churchman SM, et al. Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies. Rheumatology. 2016;kew384. doi:10.1093/rheumatology/kew384
   Web of Science ®Google Scholar
• De Martinis M, Sirufo MM, Suppa M, Ginaldi L. IL-33/IL-31 axis in osteoporosis. Int J Mol Sci. 2020;21(4):1239. doi:10.3390/ijms21041239
   PubMed Web of Science ®Google Scholar
• Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000;106(12):1481–1488. doi:10.1172/JCI11176
   PubMed Web of Science ®Google Scholar
• Gilbert L, He X, Farmer P, et al. Inhibition of osteoblast differentiation by tumor necrosis factor-α. Endocrinology. 2000;141(11):3956–3964. doi:10.1210/endo.141.11.7739
   PubMed Web of Science ®Google Scholar
• Cao X. RANKL-RANK signaling regulates osteoblast differentiation and bone formation. Bone Res. 2018;6(1):35. doi:10.1038/s41413-018-0040-9
   PubMed Web of Science ®Google Scholar
• Zhang N, Lo C-W, Utsunomiya T, et al. PDGF-BB and IL-4 co-overexpression is a potential strategy to enhance mesenchymal stem cell-based bone regeneration. Stem Cell Res Ther. 2021;12(1):40. doi:10.1186/s13287-020-02086-8
   PubMed Web of Science ®Google Scholar
• Xiong Y, Yan C, Chen L, et al. IL‐10 induces MC3T3‐E1 cells differentiation towards osteoblastic fate in murine model. J Cell Mol Med. 2020;24(1):1076–1086. doi:10.1111/jcmm.14832
   PubMed Web of Science ®Google Scholar
• Lee B, Oh Y, Jo S, Kim T-H, Ji JD. A dual role of TGF-β in human osteoclast differentiation mediated by Smad1 versus Smad3 signaling. Immunol Lett. 2019;206:33–40. doi:10.1016/j.imlet.2018.12.003
   PubMed Web of Science ®Google Scholar
• Chen G, Deng C, Li Y-P. TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 2012;8(2):272–288. doi:10.7150/ijbs.2929
   PubMed Web of Science ®Google Scholar
• Wan H, Qian T-Y, Hu X-J, Huang C-Y, Yao W-F. Correlation of serum CCL3/MIP-1α levels with disease severity in postmenopausal osteoporotic females. Balkan Med J. 2018;35(4):320–325. doi:10.4274/balkanmedj.2017.1165
   PubMed Web of Science ®Google Scholar
• Fu R, Liu H, Zhao S, et al. Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease. Cancer Cell Int. 2014;14(1):132. doi:10.1186/s12935-014-0132-6
   PubMed Web of Science ®Google Scholar
• Brylka LJ, Schinke T. Chemokines in physiological and pathological bone remodeling. Front Immunol. 2019;10. doi:10.3389/fimmu.2019.02182
   PubMed Web of Science ®Google Scholar
• Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42(4):607–612. doi:10.1016/j.immuni.2015.04.005
   PubMed Web of Science ®Google Scholar
• Deng J, Wang X, Chen Q, et al. B1a cells play a pathogenic role in the development of autoimmune arthritis. Oncotarget. 2016;7(15):19299–19311. doi:10.18632/oncotarget.8244
   PubMedGoogle Scholar
• Parekh VV, Prasad DVR, Banerjee PP, Joshi BN, Kumar A, Mishra GC. B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8 + T cells: role of TGF-β1. J Immunol. 2003;170(12):5897–5911. doi:10.4049/jimmunol.170.12.5897
   PubMed Web of Science ®Google Scholar
• Dar HY, Rani L, Sapra L, et al. A chronological journey of breg subsets: implications in health and disease. In Systems and Synthetic Immunology. Springer Singapore; 2020:125–152. doi:10.1007/978-981-15-3350-1_5
   Google Scholar
• Evans KE, Fox SW. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol. 2007;8(1):4. doi:10.1186/1471-2121-8-4
   PubMedGoogle Scholar
• Ding Q, Yeung M, Camirand G, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest. 2011;121(9):3645–3656. doi:10.1172/JCI46274
   PubMed Web of Science ®Google Scholar
• Daien CI, Gailhac S, Mura T, et al. Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity. Arthritis Rheumatol. 2014;66(8):2037–2046. doi:10.1002/art.38666
   PubMed Web of Science ®Google Scholar
• Xu L, Liu X, Liu H, et al. Impairment of gB-producing regulatory B cells correlates with exacerbated rheumatoid arthritis. Front Immunol. 2017;8. doi:10.3389/fimmu.2017.00768
   Web of Science ®Google Scholar
• Zacca ER, Onofrio LI, Acosta CDV, et al. PD-L1+ regulatory B cells are significantly decreased in rheumatoid arthritis patients and increase after successful treatment. Front Immunol. 2018;9. doi:10.3389/fimmu.2018.02241
   PubMed Web of Science ®Google Scholar